#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	24186	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2253	1059.9	0	.	n	.	0	C451T	SNP	451	451	C	698	698	T	1351	T,C	1063,249	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	24186	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2253	1059.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	1333	C,T	1288,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	24186	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2253	1059.9	0	HET	.	.	.	C207T,G	.	207	207	C	454	454	C	1366	C,T,G	1051,247,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	45554	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3626	1244.6	0	.	n	.	0	T695C	SNP	695	695	T	1064	1064	C	1415	C,T,A	1366,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	45554	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3626	1244.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	2007	2007	G	1428	G,A	1374,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	45554	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3626	1244.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2340	2340	C	1321	C,T	1268,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	45554	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3626	1244.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2414	2414	A	1329	A	1291	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	45554	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3626	1244.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2966	2966	C	1420	C	1373	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2756	folP	855	855	100.0	folP.l15.c4.ctg.1	1586	171.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1090	1092	AGC	281;281;281	A;G;C,A	268;270;269,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8722	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3427	251.8	1	SNP	p	S91F	1	.	.	271	273	TTC	612	614	TTC	331;327;325	T;T;C	319;318;311	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8722	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3427	251.8	1	SNP	p	G95N	0	.	.	283	285	GGC	624	626	GGC	321;319;317	G;G;C	307;306;305	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8722	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3427	251.8	1	SNP	p	D95G	1	.	.	283	285	GGC	624	626	GGC	321;319;317	G;G;C	307;306;305	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2474	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1255	195.4	1	SNP	p	G45D	0	.	.	133	135	GGC	436	438	GGC	298;293;293	G;G;C	286;279;281	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	787	1260	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1025	121.6	0	.	n	.	0	A197.	DEL	197	197	A	398	398	T	301	T	287	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	289.7	1	SNP	p	D86N	0	.	.	256	258	GAC	532	534	GAC	328;328;333	G;A;C	317;308;323	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	289.7	1	SNP	p	R87W	0	.	.	259	261	CGT	535	537	CGT	333;333;337	C;G;T	324;322;321	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	289.7	1	SNP	p	S87R	1	.	.	259	261	CGT	535	537	CGT	333;333;337	C;G;T	324;322;321	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	289.7	1	SNP	p	R87I	0	.	.	259	261	CGT	535	537	CGT	333;333;337	C;G;T	324;322;321	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8538	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	289.7	1	SNP	p	S88P	0	.	.	262	264	TCC	538	540	TCC	330;326;325	T;C;C,G	321;315;314,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6014	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2693	220.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	331;329;326	G;G;C,T	315;314;305,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1193	1195	GCC	335;337;336	G;C;C	317;324;323	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1196	1198	ATG	336;336;333	A;T;G,A	326;322;320,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1208	1210	ACC	344;344;348	A;C,A;C	328;333,1;337	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1208	1210	ACC	344;344;348	A;C,A;C	328;333,1;337	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1709	1711	ACC	287;284;288	A;C;C	267;270;274	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1763	1765	GCG	278;277;281	G;C;G	268;265;268	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1763	1765	GCG	278;277;281	G;C;G	268;265;268	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1886	1888	GGT	256;255;251	G;G;T	241;242;234	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1895	1897	AGC	231;229;229	A;G;C	216;220;216	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	6370	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2330	269.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1913	1915	CCG	167;166;161	C,G;C,G;G	146,7;145,1;144	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9416	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3027	307.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1622	1624	CCG	342;343;340	C;C;G	315;325;316	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3478	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1671	205.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	509	509	C	247	C	233	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4904	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1820	266.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	992	994	AGA	432;429;426	A;G;A	421;410;411	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4904	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1820	266.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1013	1015	GGT	427;434;432	G,A;G;T	412,1;420;414	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4904	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1820	266.6	1	SNP	p	G120K	1	.	.	358	360	AAG	722	724	AAG	400;403;403	A,C;A;G	386,1;395;380	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4904	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1820	266.6	1	SNP	p	A121N	1	.	.	361	363	AAC	725	727	AAC	408;407;410	A;A;C	389;392;392	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4904	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1820	266.6	1	SNP	p	N121D	0	.	.	361	363	AAC	725	727	AAC	408;407;410	A;A;C	389;392;392	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	17272	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4734	360.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1956	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1023	189.1	1	SNP	p	V57M	1	.	.	169	171	ATG	542	544	ATG	382;388;387	A;T;G	365;368;373	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
